New York Life Investments ETF Trust NYLIM U.S. Large Cap R&D Leaders ETF
LRND
3 hedge funds and large institutions have $4.89M invested in New York Life Investments ETF Trust NYLIM U.S. Large Cap R&D Leaders ETF in 2023 Q2 according to their latest regulatory filings, with 2 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
200% more funds holding
Funds holding: 1 → 3 (+2)
12% more capital invested
Capital invested by funds: $4.36M → $4.89M (+$526K)
0.02% more ownership
Funds ownership: 95% → 95.02% (+0.02%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AssetMark Inc
Concord,
California
|
+$716 |
| 2 |
TRCT
Tower Research Capital (TRC)
New York
|
+$24 |
Top Sellers
LRND Hedge Fund Activity: Q2 2023 in Review
3 of the 6,385 institutional investors tracked by Wall St. Rank reported a position in New York Life Investments ETF Trust NYLIM U.S. Large Cap R&D Leaders ETF (LRND) for Q2 2023, worth a combined $4.89M — up 12% from $4.36M a quarter earlier.
Buyers outnumbered sellers: 2 funds opened new LRND positions and 0 closed out — a net gain of 2 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was AssetMark Inc, opening a new position worth an estimated $716.
- 3 institutional investors held New York Life Investments ETF Trust NYLIM U.S. Large Cap R&D Leaders ETF (LRND) as of Q2 2023, up from 1 in Q1 2023.
- Funds reported $4.89M of New York Life Investments ETF Trust NYLIM U.S. Large Cap R&D Leaders ETF stock for Q2 2023, up 12% quarter-over-quarter.
- 2 funds opened new New York Life Investments ETF Trust NYLIM U.S. Large Cap R&D Leaders ETF positions in Q2 2023 and 0 closed out, a net change of +2 holders.
- The largest New York Life Investments ETF Trust NYLIM U.S. Large Cap R&D Leaders ETF buyer in Q2 2023 was AssetMark Inc, an estimated $716 added.
Based on aggregated 13F filings for Q2 2023.